Drug-resistant Streptococcus pneumoniae infections: clinical importance, drug treatment, and prevention

Area of Science:

• Infectious Diseases
• Microbiology
• Public Health

Background:

• Drug-resistant Streptococcus pneumoniae (DRSP) infections present significant global management challenges.
• Key risk factors for DRSP include prior antibiotic exposure, young age, immunosuppression, and healthcare settings.
• While intermediate resistance may not affect mortality, highly resistant strains of Streptococcus pneumoniae are increasingly linked to adverse outcomes.

Purpose of the Study:

• To review the clinical implications and management strategies for drug-resistant Streptococcus pneumoniae (DRSP) infections.
• To highlight factors contributing to the development and transmission of DRSP.
• To emphasize the role of antibiotic stewardship and vaccination in controlling pneumococcal infections.

Main Methods:

• Review of existing literature on drug-resistant Streptococcus pneumoniae (DRSP) epidemiology, risk factors, and clinical outcomes.
• Analysis of treatment considerations based on infection site, severity, and antibiotic susceptibility data.
• Evaluation of public health interventions for DRSP prevention.

Main Results:

• Clinical and bacteriologic failures are more frequent in DRSP meningitis and otitis media.
• Evidence suggests highly resistant Streptococcus pneumoniae isolates may increase mortality.
• Appropriate therapy selection requires assessing patient risk factors, infection characteristics, and susceptibility data.

Conclusions:

• Reducing DRSP impact necessitates community-level antibiotic use reduction and better understanding of resistance mechanisms.
• Increased use of polysaccharide and conjugate vaccines is crucial for preventing Streptococcus pneumoniae infections.
• Multifaceted approaches combining antibiotic stewardship and vaccination are essential for controlling DRSP.